← Back to Clinical Trials
Recruiting NCT06928727

NCT06928727 Ocular Characteristics in Patients With Craniosynostosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06928727
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Craniosynostosis
Study Type OBSERVATIONAL
Enrollment 65 participants
Start Date 2025-04-04
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 65 participants in total. It began in 2025-04-04 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Craniosynostosis are cranial deformations due to the premature closure of one or more cranial sutures. These deformations affect approximately one in 2.500 births. In most cases, craniosynostoses are isolated with unknown (non syndrome). On the other hand, 20% of these deformations are associated with other concentration (syndrome). Craniosynostosis has morphological (associated dysmorphism) and functional (growth conflict between the skull and the brain) repercussions. Ophthalmological disorders are frequent: refractive disorders, oculomotor disorders, optic nerve damage, sensory damage. This retrospective study aims to describe the ocular clinical characteristics associated with craniosynostosis in patients followed at the Amiens University Hospital.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of craniostenosis Exclusion Criteria: * Posterior plagiocephalia

Contact & Investigator

Central Contact

Tran Thi Ha Chau, Pr

✉ tran.chau@chu-amiens.fr

📞 33+322089224

Frequently Asked Questions

Who can join the NCT06928727 clinical trial?

This trial is open to participants of all sexes, studying Craniosynostosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06928727 currently recruiting?

Yes, NCT06928727 is actively recruiting participants. Contact the research team at tran.chau@chu-amiens.fr for enrollment information.

Where is the NCT06928727 trial being conducted?

This trial is being conducted at Amiens, France.

Who is sponsoring the NCT06928727 clinical trial?

NCT06928727 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 65 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology